These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7376941)

  • 1. Evaluation of the humoral response of meningioma patients to possible common tumour-associated antigens.
    Mottet S; Martin-Achard A; de Tribolet N; Diserens AC
    Acta Neurochir (Wien); 1980; 52(1-2):19-25. PubMed ID: 7376941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous antibodies to meningioma cell surface antigens.
    Pfreundschuh M; Röhrich M; Piotrowksi W; Penzholz H; Fischer H
    Anticancer Res; 1981; 1(6):367-72. PubMed ID: 6284017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the humoral response of glioma patients to a possible common tumor-associated antigen(s).
    Martin-Achard A; Diserens AC; de Tribolet N; Carrel S
    Int J Cancer; 1980 Feb; 25(2):219-24. PubMed ID: 7390650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of common antigens in primary and recurrent human meningiomas by radioimmunoassays and other serologic tests.
    Winters WD
    Cancer Detect Prev; 1983; 6(1-2):325-31. PubMed ID: 6883390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of proliferating cell nuclear antigen (PCNA) in intracranial glioma and meningioma.
    Shih YH; Kadota Y; Sato K; Sueyoshi N; Shirai T
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Apr; 53(4):193-7. PubMed ID: 7911730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical demonstration of IgG in meningioma.
    Tabuchi K; Kawakami Y; Nishimoto A
    Acta Neurochir (Wien); 1981; 55(3-4):201-11. PubMed ID: 7015802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum immunoglobulins in brain tumours.
    Manjula S; Aroor AR; Raja A; Rao SN; Rao A
    Acta Neurochir (Wien); 1992; 115(3-4):103-5. PubMed ID: 1605076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological analysis of tumor antigens in malignant glioma patients.
    Yoshida S; Tanaka R; Ono K
    Neurol Med Chir (Tokyo); 1991 Sep; 31(9):559-62. PubMed ID: 1723168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired thymus-derived lymphocyte function in patients with malignant brain tumour.
    Menzies CB; Gunar M; Thomas DG; Behan PO
    Clin Neurol Neurosurg; 1980; 82(3):157-68. PubMed ID: 6260411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic immune response of meningioma patients towards allogeneic and autologous tumour cells before and after surgery.
    Pees HW
    Acta Neurochir (Wien); 1979; 50(3-4):217-27. PubMed ID: 517190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination for invasive canine meningioma induces in situ production of antibodies capable of antibody-dependent cell-mediated cytotoxicity.
    Andersen BM; Pluhar GE; Seiler CE; Goulart MR; SantaCruz KS; Schutten MM; Meints JP; O'Sullivan MG; Bentley RT; Packer RA; Thomovsky SA; Chen AV; Faissler D; Chen W; Hunt MA; Olin MR; Ohlfest JR
    Cancer Res; 2013 May; 73(10):2987-97. PubMed ID: 23471847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human meningioma antigens.
    Winters WD; Rich JR
    Int J Cancer; 1975 May; 15(5):815-22. PubMed ID: 806546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar immunity profiles in patients with meningioma and glioma tumors despite differences in the apoptosis and necrosis of circulating lymphocyte and monocyte populations.
    Kataki A; Skandami V; Memos N; Nikolopoulou M; Oikonomou V; Androulis A; Konstadoulakis MM; Zografos CG
    J Neurosurg Sci; 2014 Mar; 58(1):9-15. PubMed ID: 24614787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex humoral immune response against a benign tumor: frequent antibody response against specific antigens as diagnostic targets.
    Comtesse N; Zippel A; Walle S; Monz D; Backes C; Fischer U; Mayer J; Ludwig N; Hildebrandt A; Keller A; Steudel WI; Lenhof HP; Meese E
    Proc Natl Acad Sci U S A; 2005 Jul; 102(27):9601-6. PubMed ID: 15983380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human intracranial tumors: effect of autologous serum addition on leucocyte migration inhibition.
    Böker DK
    Acta Neurochir (Wien); 1982; 65(3-4):227-37. PubMed ID: 7180599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel immunogenic antigens increase classification accuracy in meningioma to 93.84%.
    Ludwig N; Keller A; Heisel S; Leidinger P; Rheinheimer S; Andres C; Stephan B; Steudel WI; Donauer E; Graf N; Burgeth B; Weickert J; Lenhof HP; Meese E
    Int J Cancer; 2011 Mar; 128(6):1493-501. PubMed ID: 20506373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utilization of native glioma antigens in the assessment of cellular and humoral immune responses in malignant glioma patients.
    Apuzzo ML; Sheikh KM; Weiss MH; Heiden JS; Kurze T
    Acta Neurochir (Wien); 1981; 55(3-4):181-200. PubMed ID: 7015801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence automatic cell sorter and immunohistochemical investigation of CD68-positive cells in meningioma.
    Asai J; Suzuki R; Fujimoto T; Suzuki T; Nakagawa N; Nagashima G; Miyo T; Hokaku H; Takei A
    Clin Neurol Neurosurg; 1999 Dec; 101(4):229-34. PubMed ID: 10622450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific cellular immune responses in patients with malignant gliomas.
    Sheikh KM; Apuzzo ML; Weiss MH
    Cancer Res; 1979 May; 39(5):1733-8. PubMed ID: 85487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common antigen in meningioma-derived cell cultures.
    Catalano LW; Harter DH; Hsu KC
    Science; 1972 Jan; 175(4018):180-2. PubMed ID: 4332758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.